These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8666802)
1. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase. Kremer L; Riveau G; Baulard A; Capron A; Locht C J Immunol; 1996 Jun; 156(11):4309-17. PubMed ID: 8666802 [TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium. Kremer L; Dupré L; Riveau G; Capron A; Locht C Infect Immun; 1998 Dec; 66(12):5669-76. PubMed ID: 9826340 [TBL] [Abstract][Full Text] [Related]
3. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice. Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021 [TBL] [Abstract][Full Text] [Related]
4. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene. Kayes SG; Shaneyfelt RC; Monteiro C; O'Brien JJ J Parasitol; 1998 Aug; 84(4):764-70. PubMed ID: 9714208 [TBL] [Abstract][Full Text] [Related]
5. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703 [TBL] [Abstract][Full Text] [Related]
6. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice. Varaldo PB; Miyaji EN; Vilar MM; Campos AS; Dias WO; Armôa GR; Tendler M; Leite LC; McIntosh D FEMS Immunol Med Microbiol; 2006 Oct; 48(1):132-9. PubMed ID: 16965361 [TBL] [Abstract][Full Text] [Related]
7. Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella. Khan CM; Villarreal-Ramos B; Pierce RJ; Demarco de Hormaeche R; McNeill H; Ali T; Chatfield S; Capron A; Dougan G; Hormaeche CE J Immunol; 1994 Dec; 153(12):5634-42. PubMed ID: 7527446 [TBL] [Abstract][Full Text] [Related]
8. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. El Ridi R; Tallima H Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448 [TBL] [Abstract][Full Text] [Related]
9. Expression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential. Rao KV; He YX; Kalyanasundaram R Clin Diagn Lab Immunol; 2003 Jul; 10(4):536-41. PubMed ID: 12853382 [TBL] [Abstract][Full Text] [Related]
10. Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. Remoué F; Rogerie F; Gallissot MC; Guyatt HL; Neyrinck JL; Diakkhate MM; Niang M; Butterworth AE; Auriault C; Capron A; Riveau G J Infect Dis; 2000 May; 181(5):1855-9. PubMed ID: 10823801 [TBL] [Abstract][Full Text] [Related]
11. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Khan CM; Villarreal-Ramos B; Pierce RJ; Riveau G; Demarco de Hormaeche R; McNeill H; Ali T; Fairweather N; Chatfield S; Capron A Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11261-5. PubMed ID: 7972044 [TBL] [Abstract][Full Text] [Related]
12. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase. Dupré L; Poulain-Godefroy O; Ban E; Ivanoff N; Mekranfar M; Schacht AM; Capron A; Riveau G Parasite Immunol; 1997 Nov; 19(11):505-13. PubMed ID: 9427997 [TBL] [Abstract][Full Text] [Related]
13. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes. Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373 [TBL] [Abstract][Full Text] [Related]
14. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice]. Dai W; Huangfu Y; Zheng B Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. El Ridi R; Montash M; Tallima H Scand J Immunol; 2004 Oct; 60(4):392-402. PubMed ID: 15379864 [TBL] [Abstract][Full Text] [Related]
16. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects. James SL; DeBlois LA J Immunol; 1986 May; 136(10):3864-71. PubMed ID: 3084645 [TBL] [Abstract][Full Text] [Related]
17. [Studies on the features of protective immune response induced by recombinant Sjc26GST of Schistosoma japonicum]. Zhou S; Liu S; Song G; Xu Y Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(2):74-7. PubMed ID: 12563784 [TBL] [Abstract][Full Text] [Related]
18. IgA antibodies to a protective antigen in human Schistosomiasis mansoni. Grzych JM; Grezel D; Xu CB; Neyrinck JL; Capron M; Ouma JH; Butterworth AE; Capron A J Immunol; 1993 Jan; 150(2):527-35. PubMed ID: 8419485 [TBL] [Abstract][Full Text] [Related]
19. Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide. Pancré V; Gras-Masse H; Delanoye A; Herno J; Capron A; Auriault C Scand J Immunol; 1996 Nov; 44(5):485-92. PubMed ID: 8947600 [TBL] [Abstract][Full Text] [Related]
20. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]